GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Applied Biosciences Corp (OTCPK:APPB) » Definitions » Total Payout Ratio

Applied Biosciences (Applied Biosciences) Total Payout Ratio : 0.00 (As of Jun. 10, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Applied Biosciences Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Applied Biosciences's current Total Payout Ratio is 0.00.


Applied Biosciences Total Payout Ratio Historical Data

The historical data trend for Applied Biosciences's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied Biosciences Total Payout Ratio Chart

Applied Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18
Total Payout Ratio
2.50 - 0.11 2.18 0.29

Applied Biosciences Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Applied Biosciences's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Applied Biosciences's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied Biosciences's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Applied Biosciences's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Applied Biosciences's Total Payout Ratio falls into.



Applied Biosciences Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Applied Biosciences's Total Payout Ratio for the fiscal year that ended in Mar. 2018 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0.1 + 0.795 + 0) / -2.387
=0.29

Applied Biosciences's Total Payout Ratio for the quarter that ended in Dec. 2019 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -1.426
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Applied Biosciences Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Applied Biosciences's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied Biosciences (Applied Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
320 Park Avenue, 18th Floor, New York, NY, USA, 10022
Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to its customers.
Executives
Michael Beaubaire director 9701 WILSHIRE BLVD. SUITE 1000 BEVERLY HILLS CA 90212
John Robert Brady 10 percent owner 9701 WILSHIRE BLVD., SUITE 1000 BEVERLY HILLS CA 90212
Raymond W. Urbanski director, officer: Chief Executive Officer 28903 NORTH AVENUE PAINE, VALENCIA CA 91355
Scott B Stevens director 9701 WILSHIRE BLVD., SUITE 1000, BEVERLY HILLS CA 90212
Chris Bridges director, officer: President 9701 WILSHIRE BLVD., SUITE 1000 BEVERLY HILLS CA 90212
John James Southard officer: Secretary and Treasurer 9701 WILSHIRE BLVD., SUITE 1000 BEVERLY HILLS CA 90212
Sbs Family Trust 10 percent owner 521 RXR PLAZA EAST TOWER ? SUITE 521 UNIONDALE NY 11556